indazoles and pha 408
indazoles has been researched along with pha 408 in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chiang, PC; Kishore, NN; Thompson, DC | 1 |
| Hwang, JW; Kishore, N; Rahman, I; Rajendrasozhan, S; Yao, H | 1 |
| Hall, T; Kishore, N; Kurumbail, RG; Mathialagan, S; Mbalaviele, G; Poda, GI; Reitz, BA; Selness, SR; Weinberg, RA | 1 |
| Bonar, SL; Brustkern, SJ; Chen, NX; Christine, L; Heier, RF; Hu, Y; Huang, HC; Kishore, NN; Kurumbail, RG; Lennon, PJ; Li, X; Mathialagan, S; Poda, GI; Reding, MT; Selness, SR; Sommers, CD; Venkatraman, N; Wolfson, SG; Xie, J | 1 |
| Chuang, TH; Hsu, LC; Lai, CY; Lin, KI; Su, YW | 1 |
Reviews
1 review(s) available for indazoles and pha 408
| Article | Year |
|---|---|
Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Cytokines; Dermatitis; Endosomes; Humans; Imiquimod; Indazoles; Isonicotinic Acids; Mice; Psoriasis; Resveratrol; Signal Transduction; Skin; Stilbenes; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptor 9; Toll-Like Receptors | 2017 |
Other Studies
4 other study(ies) available for indazoles and pha 408
| Article | Year |
|---|---|
Combined use of pharmacokinetic modeling and a steady-state delivery approach allows early assessment of IkappaB kinase-2 (IKK-2) target safety and efficacy.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Evaluation, Preclinical; Female; I-kappa B Kinase; Indazoles; Isonicotinic Acids; Male; Models, Biological; Rats; Rats, Inbred Lew; Rats, Wistar; Tumor Necrosis Factor-alpha | 2010 |
Anti-inflammatory effect of a selective IkappaB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke.
Topics: Animals; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; I-kappa B Kinase; Indazoles; Inflammation Mediators; Isonicotinic Acids; Lipopolysaccharides; Lung; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Smoking | 2010 |
Expression, purification and functional characterization of IkappaB kinase-2 (IKK-2) mutants.
Topics: Animals; Cells, Cultured; Computer Simulation; Drug Discovery; Humans; I-kappa B Kinase; Indazoles; Isonicotinic Acids; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Phosphorylation; Protein Binding; Recombinant Proteins; Spodoptera; Structural Homology, Protein | 2010 |
Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure-activity relationship.
Topics: Administration, Inhalation; Aminopyridines; Asthma; Binding, Competitive; Drug Design; HEK293 Cells; Humans; I-kappa B Kinase; Indazoles; Isonicotinic Acids; Microsomes, Liver; Models, Molecular; Molecular Structure; Molecular Targeted Therapy; Niacinamide; Phenethylamines; Potassium Channel Blockers; Protein Kinase Inhibitors; Pulmonary Disease, Chronic Obstructive; Pyrazoles; Structure-Activity Relationship; Sulfonamides | 2011 |